Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease? - Thau, Henriette; Neuber, Sebastian; Emmert, Maximilian Y.; Nazari-Shafti, Timo Z. (Cardiology and Therapy, 2024)
Keywords: Apolipoproteins; Cardiology; Cardiovascular disease; Cardiovascular diseases; Coronary heart disease; Elevated Lp(a) levels; Fomivirsen; Genetic aspects; Health aspects; Heart failure; Internal Medicine; Lepodisiran (LY3819469); Lipoprotein A; Low density lipoproteins; Measurement; Medicine; Medicine & Public Health; Mipomersen; Olpasiran; Pelacarsen; Prevention; Review; Risk factors; Germany; Lepodisiran (LY3819469); Therapy; Lipoprotein(a); Elevated Lp(a) levels; Olpasiran; Pelacarsen; Cardiovascular disease; RNA therapeutics; SLN360